Banner Health News Center  

Alzheimer's Prevention Initiative in the News

 

 
Alzheimers Prevention Initiative

The Banner Alzheimer's Institute is collaborating on the first-ever study of an experimental drug that is hoped to stop Alzheimer's before it starts.

The study, a partnership between BAI, Genentech and National Institutes of Health and other research leaders, is the cornerstone of a new international collaborative, the Alzheimer’s Prevention Initiative (API).


Learn how you can be part of the effort to fight Alzheimer's right arrow

The study will involve about 300 participants from Colombian families who share a rare genetic mutation that typically triggers Alzheimer’s symptoms around age 45. The study will also include a small number of individuals in the United States.

In the news:

Follow Us:  
Facebook IconPinterestTwitter IconYouTube Icon
 
 
 
Jump to top links